Post-kala-azar dermal leishmaniasis manifesting after initiation of highly active anti-retroviral therapy in a patient with human immunodeficiency virus infection

Jacob Gilad, Abraham Borer, Dafna Hallel-Halevy, Klaris Riesenberg, Michael Alkan, Francisc Schlaeffer*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)451-452
Number of pages2
JournalIsrael Medical Association Journal
Issue number6
StatePublished - 2001
Externally publishedYes


  • Dermal leishmaniasis
  • Highly active anti-retroviral therapy
  • Human immunodeficiency virus
  • Immune reconstitution
  • Kala-azar

Cite this